Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...

Man patients with MIBC are ineligible for or refuse SOC cisplatin. SunRISe-4 evaluated neoadjuvant gemcitabine intravesical system (TAR-200) plus cetrelimab or cetrelimab monotherapy for pathologic ...

From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments in bladder cancer frequently have made news over the past 12 months. The ...

A bladder prolapse (cystocele) is a common condition in which your bladder pushes into your vagina due to weakened pelvic muscles. It’s highly treatable with exercise or surgery. Bladder prolapse ...

Urology departments in England and Wales have seen an increase in bladder inflammation among 16 to 24-year-olds ...